<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0001039803</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>

      <seriesClassInfo>
        <seriesId>S000003093</seriesId>
        <classId>C000008401</classId>
        <classId>C000008402</classId>
      </seriesClassInfo>


    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>ProFunds</regName>
      <regFileNumber>811-08239</regFileNumber>
      <regCik>0001039803</regCik>
      <regLei>549300HM4OOUYSE5DP77</regLei>
      <regStreet1>7272 Wisconsin Avenue</regStreet1>
      <regStreet2>21st Floor</regStreet2>
      <regCity>Bethesda</regCity>
      <regStateConditional regCountry="US" regState="US-MD"/>
      <regZipOrPostalCode>20814</regZipOrPostalCode>
      <regPhone>240-497-6400</regPhone>
      <seriesName>PHARMACEUTICALS ULTRASECTOR PROFUND</seriesName>
      <seriesId>S000003093</seriesId>
      <seriesLei>O4X73XQHFKFTUZE9BD44</seriesLei>
      <repPdEnd>2026-07-31</repPdEnd>
      <repPdDate>2026-01-31</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>7967330.85</totAssets>
      <totLiabs>4184304.58</totLiabs>
      <netAssets>3783026.27</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>655.75</cshNotRptdInCorD>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000008401" rtn1="15.00678000" rtn2="3.51731800" rtn3="-2.45676200"/>
          <monthlyTotReturn classId="C000008402" rtn1="14.96066200" rtn2="3.42458100" rtn3="-2.50944600"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <equityContracts>
            <mon1 netRealizedGain="173825.68000000" netUnrealizedAppr="40674.19000000"/>
            <mon2 netRealizedGain="176893.48000000" netUnrealizedAppr="-104559.02000000"/>
            <mon3 netRealizedGain="-35514.84000000" netUnrealizedAppr="-31703.63000000"/>
            <swapCategory>
              <instrMon1 netRealizedGain="173825.68000000" netUnrealizedAppr="40674.18999999"/>
              <instrMon2 netRealizedGain="176893.48000000" netUnrealizedAppr="-104559.02000000"/>
              <instrMon3 netRealizedGain="-35514.84000000" netUnrealizedAppr="-31703.63000000"/>
            </swapCategory>
          </equityContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="13580.66000000" netUnrealizedAppr="233812.87000000"/>
        <othMon2 netRealizedGain="107242.65000000" netUnrealizedAppr="-44375.45000000"/>
        <othMon3 netRealizedGain="-6084.59000000" netUnrealizedAppr="-53994.80000000"/>
      </returnInfo>
      <mon1Flow redemption="3602900.66000000" reinvestment="0.00000000" sales="4472039.28000000"/>
      <mon2Flow redemption="6154288.43000000" reinvestment="31936.87000000" sales="5823520.66000000"/>
      <mon3Flow redemption="4897627.07000000" reinvestment="0.00000000" sales="4721986.28000000"/>
      <varInfo>

        <fundsDesignatedInfo>
          <nameDesignatedIndex>Dow Jones U.S. Select Pharmaceuticals Index</nameDesignatedIndex>
          <indexIdentifier>DJSPHM</indexIdentifier>

        </fundsDesignatedInfo>

      </varInfo>
    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>ANI Pharmaceuticals Inc.</name>
        <lei>5493000T6CXTND40YH31</lei>
        <title>ANI Pharmaceuticals, Inc. </title>
        <cusip>00182C103</cusip>
        <identifiers>
          <isin value="US00182C1036"/>
        </identifiers>
        <balance>704.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57622.40000000</valUSD>
        <pctVal>1.523182655562</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alumis Inc</name>
        <lei>N/A</lei>
        <title>Alumis, Inc. </title>
        <cusip>022307102</cusip>
        <identifiers>
          <isin value="US0223071020"/>
        </identifiers>
        <balance>1017.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>24926.67000000</valUSD>
        <pctVal>0.658908192038</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amneal Pharmaceuticals Inc</name>
        <lei>549300VV176ZO5WQHZ61</lei>
        <title>Amneal Pharmaceuticals, Inc. </title>
        <cusip>03168L105</cusip>
        <identifiers>
          <isin value="US03168L1052"/>
        </identifiers>
        <balance>4729.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>64692.72000000</valUSD>
        <pctVal>1.710078529272</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amphastar Pharmaceuticals Inc</name>
        <lei>54930055TH0ZLSAQMJ38</lei>
        <title>Amphastar Pharmaceuticals, Inc. </title>
        <cusip>03209R103</cusip>
        <identifiers>
          <isin value="US03209R1032"/>
        </identifiers>
        <balance>1897.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>50251.53000000</valUSD>
        <pctVal>1.328342084180</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amylyx Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Amylyx Pharmaceuticals, Inc. </title>
        <cusip>03237H101</cusip>
        <identifiers>
          <isin value="US03237H1014"/>
        </identifiers>
        <balance>4364.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>62361.56000000</valUSD>
        <pctVal>1.648456964059</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aquestive Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Aquestive Therapeutics, Inc. </title>
        <cusip>03843E104</cusip>
        <identifiers>
          <isin value="US03843E1047"/>
        </identifiers>
        <balance>6279.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18523.05000000</valUSD>
        <pctVal>0.489635775117</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arvinas Inc</name>
        <lei>N/A</lei>
        <title>Arvinas, Inc. </title>
        <cusip>04335A105</cusip>
        <identifiers>
          <isin value="US04335A1051"/>
        </identifiers>
        <balance>4362.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>58363.56000000</valUSD>
        <pctVal>1.542774377826</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Axsome Therapeutics Inc.</name>
        <lei>549300EXGR0XLRJEIB95</lei>
        <title>Axsome Therapeutics, Inc. </title>
        <cusip>05464T104</cusip>
        <identifiers>
          <isin value="US05464T1043"/>
        </identifiers>
        <balance>387.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>71304.75000000</valUSD>
        <pctVal>1.884860027683</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>PHPIX_SPSIPH_GOLDMAN</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="1076GSWPL"/>
        </identifiers>
        <balance>335.00000000</balance>
        <units>OU</units>
        <curCd>USD</curCd>
        <valUSD>-36685.91000000</valUSD>
        <pctVal>-0.96975033694</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerConditional desc="Total Return Swap" issuerCat="OTHER"/>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <derivativeInfo>
          <swapDeriv derivCat="SWP">
            <counterparties>
              <counterpartyName>GOLDMAN SACHS GROUP, INC.</counterpartyName>
              <counterpartyLei>784F5XWPLTWKTBV3E584</counterpartyLei>
            </counterparties>
            <descRefInstrmnt>
              <indexBasketInfo>
                <indexName>DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</indexName>
                <indexIdentifier>SPSIPH Index</indexIdentifier>
                <narrativeDesc>This swap is not based on custom baskets or indices</narrativeDesc>
              </indexBasketInfo>
            </descRefInstrmnt>
            <swapFlag>Y</swapFlag>
            <otherRecDesc fixedOrFloating="Other">DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</otherRecDesc>
            <floatingPmntDesc curCd="USD" fixedOrFloating="Floating" floatingRtIndex="FEDL01" floatingRtSpread="0.00750000" pmntAmt="335.00000000">
              <rtResetTenors>
                <rtResetTenor rateTenor="Month" rateTenorUnit="1" resetDt="Month" resetDtUnit="1"/>
              </rtResetTenors>
            </floatingPmntDesc>
            <terminationDt>2026-02-23</terminationDt>
            <upfrontPmnt>0.00000000</upfrontPmnt>
            <pmntCurCd>USD</pmntCurCd>
            <upfrontRcpt>0.00000000</upfrontRcpt>
            <rcptCurCd>USD</rcptCurCd>
            <notionalAmt>2121139.60000000</notionalAmt>
            <curCd>USD</curCd>
            <unrealizedAppr>-36685.91000000</unrealizedAppr>
          </swapDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>PHPIX_SPSIPH_GOLDMAN</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="1076GSWPS"/>
        </identifiers>
        <balance>-106.00000000</balance>
        <units>OU</units>
        <curCd>USD</curCd>
        <valUSD>7376.40000000</valUSD>
        <pctVal>0.194986750647</pctVal>
        <payoffProfile>Short</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerConditional desc="Total Return Swap" issuerCat="OTHER"/>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <derivativeInfo>
          <swapDeriv derivCat="SWP">
            <counterparties>
              <counterpartyName>GOLDMAN SACHS GROUP, INC.</counterpartyName>
              <counterpartyLei>784F5XWPLTWKTBV3E584</counterpartyLei>
            </counterparties>
            <descRefInstrmnt>
              <indexBasketInfo>
                <indexName>DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</indexName>
                <indexIdentifier>SPSIPH Index</indexIdentifier>
                <narrativeDesc>This swap is not based on custom baskets or indices</narrativeDesc>
              </indexBasketInfo>
            </descRefInstrmnt>
            <swapFlag>Y</swapFlag>
            <floatingRecDesc curCd="USD" fixedOrFloating="Floating" floatingRtIndex="FEDL01" floatingRtSpread="0.00750000" pmntAmt="-106.00000000">
              <rtResetTenors>
                <rtResetTenor rateTenor="Month" rateTenorUnit="1" resetDt="Month" resetDtUnit="1"/>
              </rtResetTenors>
            </floatingRecDesc>
            <otherPmntDesc fixedOrFloating="Other">DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</otherPmntDesc>
            <terminationDt>2026-02-23</terminationDt>
            <upfrontPmnt>0.00000000</upfrontPmnt>
            <pmntCurCd>USD</pmntCurCd>
            <upfrontRcpt>0.00000000</upfrontRcpt>
            <rcptCurCd>USD</rcptCurCd>
            <notionalAmt>-671166.56000000</notionalAmt>
            <curCd>USD</curCd>
            <unrealizedAppr>7376.40000000</unrealizedAppr>
          </swapDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>PHPIX_SPSIPH_UBS</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="1076USWPL"/>
        </identifiers>
        <balance>211.00000000</balance>
        <units>OU</units>
        <curCd>USD</curCd>
        <valUSD>-19953.29000000</valUSD>
        <pctVal>-0.52744254403</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerConditional desc="Total Return Swap" issuerCat="OTHER"/>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <derivativeInfo>
          <swapDeriv derivCat="SWP">
            <counterparties>
              <counterpartyName>UBS SECURITIES LLC</counterpartyName>
              <counterpartyLei>T6FIZBDPKLYJKFCRVK44</counterpartyLei>
            </counterparties>
            <descRefInstrmnt>
              <indexBasketInfo>
                <indexName>DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</indexName>
                <indexIdentifier>SPSIPH Index</indexIdentifier>
                <narrativeDesc>This swap is not based on custom baskets or indices</narrativeDesc>
              </indexBasketInfo>
            </descRefInstrmnt>
            <swapFlag>Y</swapFlag>
            <otherRecDesc fixedOrFloating="Other">DOW JONES U.S. SELECT PHARMACEUTICALS INDEX</otherRecDesc>
            <floatingPmntDesc curCd="USD" fixedOrFloating="Floating" floatingRtIndex="FEDL01" floatingRtSpread="0.00800000" pmntAmt="211.00000000">
              <rtResetTenors>
                <rtResetTenor rateTenor="Month" rateTenorUnit="1" resetDt="Month" resetDtUnit="1"/>
              </rtResetTenors>
            </floatingPmntDesc>
            <terminationDt>2026-02-23</terminationDt>
            <upfrontPmnt>0.00000000</upfrontPmnt>
            <pmntCurCd>USD</pmntCurCd>
            <upfrontRcpt>0.00000000</upfrontRcpt>
            <rcptCurCd>USD</rcptCurCd>
            <notionalAmt>1336001.36000000</notionalAmt>
            <curCd>USD</curCd>
            <unrealizedAppr>-19953.29000000</unrealizedAppr>
          </swapDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bristol-Myers Squibb Company</name>
        <lei>HLYYNH7UQUORYSJQCN42</lei>
        <title>Bristol-Myers Squibb Company </title>
        <cusip>110122108</cusip>
        <identifiers>
          <isin value="US1101221083"/>
        </identifiers>
        <balance>1127.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>62041.35000000</valUSD>
        <pctVal>1.639992576630</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Collegium Pharmaceutical Inc.</name>
        <lei>54930049FXZMTLW8D496</lei>
        <title>Collegium Pharmaceutical, Inc. </title>
        <cusip>19459J104</cusip>
        <identifiers>
          <isin value="US19459J1043"/>
        </identifiers>
        <balance>1182.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>54277.44000000</valUSD>
        <pctVal>1.434762439542</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Corcept Therapeutics Inc.</name>
        <lei>529900EO9LUTFMZ7FF90</lei>
        <title>Corcept Therapeutics, Inc. </title>
        <cusip>218352102</cusip>
        <identifiers>
          <isin value="US2183521028"/>
        </identifiers>
        <balance>677.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26991.99000000</valUSD>
        <pctVal>0.713502578981</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CorMedix Inc.</name>
        <lei>5299006YIA3L0MBW8358</lei>
        <title>CorMedix, Inc. </title>
        <cusip>21900C308</cusip>
        <identifiers>
          <isin value="US21900C3088"/>
        </identifiers>
        <balance>4387.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34043.12000000</valUSD>
        <pctVal>0.899891186851</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="32328.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Crinetics Pharmaceuticals Inc.</name>
        <lei>549300Q1CNFXK5P31D28</lei>
        <title>Crinetics Pharmaceuticals, Inc. </title>
        <cusip>22663K107</cusip>
        <identifiers>
          <isin value="US22663K1079"/>
        </identifiers>
        <balance>1201.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>59977.94000000</valUSD>
        <pctVal>1.585448678367</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Definium Therapeutics Inc.</name>
        <lei>549300QY8KN1O6RPFJ13</lei>
        <title>Definium Therapeutics, Inc. </title>
        <cusip>24477V105</cusip>
        <identifiers>
          <isin value="CA24477V1058"/>
        </identifiers>
        <balance>4664.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>78728.32000000</valUSD>
        <pctVal>2.081093663671</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Edgewise Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Edgewise Therapeutics, Inc. </title>
        <cusip>28036F105</cusip>
        <identifiers>
          <isin value="US28036F1057"/>
        </identifiers>
        <balance>2432.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>68460.80000000</valUSD>
        <pctVal>1.809683441611</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Elanco Animal Health Inc</name>
        <lei>549300SHPNDCE059M934</lei>
        <title>Elanco Animal Health, Inc. </title>
        <cusip>28414H103</cusip>
        <identifiers>
          <isin value="US28414H1032"/>
        </identifiers>
        <balance>2711.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>65280.88000000</valUSD>
        <pctVal>1.725625870422</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Enliven Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Enliven Therapeutics, Inc. </title>
        <cusip>29337E102</cusip>
        <identifiers>
          <isin value="US29337E1029"/>
        </identifiers>
        <balance>2178.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57608.10000000</valUSD>
        <pctVal>1.522804651314</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Esperion Therapeutics Inc</name>
        <lei>549300OFU56UKEWVUS92</lei>
        <title>Esperion Therapeutics, Inc. </title>
        <cusip>29664W105</cusip>
        <identifiers>
          <isin value="US29664W1053"/>
        </identifiers>
        <balance>15075.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>51104.25000000</valUSD>
        <pctVal>1.350882768255</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Evolus Inc</name>
        <lei>549300VYQRYBQOT8V419</lei>
        <title>Evolus, Inc. </title>
        <cusip>30052C107</cusip>
        <identifiers>
          <isin value="US30052C1071"/>
        </identifiers>
        <balance>4490.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21058.10000000</valUSD>
        <pctVal>0.556646940757</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eyepoint Inc.</name>
        <lei>549300QE1RU34T50MR69</lei>
        <title>EyePoint Pharmaceuticals, Inc. </title>
        <cusip>30233G209</cusip>
        <identifiers>
          <isin value="US30233G2093"/>
        </identifiers>
        <balance>3453.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>46684.56000000</valUSD>
        <pctVal>1.234053286127</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harmony Biosciences Holdings Inc</name>
        <lei>N/A</lei>
        <title>Harmony Biosciences Holdings, Inc. </title>
        <cusip>413197104</cusip>
        <identifiers>
          <isin value="US4131971040"/>
        </identifiers>
        <balance>1470.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>53684.40000000</valUSD>
        <pctVal>1.419086101138</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harrow Inc</name>
        <lei>N/A</lei>
        <title>Harrow, Inc. </title>
        <cusip>415858109</cusip>
        <identifiers>
          <isin value="US4158581094"/>
        </identifiers>
        <balance>1150.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>47081.00000000</valUSD>
        <pctVal>1.244532726969</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Indivior Pharmaceuticals Inc.</name>
        <lei>213800V3NCQTY7IED471</lei>
        <title>Indivior Pharmaceuticals, Inc. </title>
        <cusip>45579U109</cusip>
        <identifiers>
          <isin value="US45579U1097"/>
        </identifiers>
        <balance>1629.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57634.02000000</valUSD>
        <pctVal>1.523489817055</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Innoviva Inc</name>
        <lei>549300ACOX4QTBES6535</lei>
        <title>Innoviva, Inc. </title>
        <cusip>45781M101</cusip>
        <identifiers>
          <isin value="US45781M1018"/>
        </identifiers>
        <balance>2800.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>56000.00000000</valUSD>
        <pctVal>1.480296355436</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Johnson &amp; Johnson</name>
        <lei>549300G0CFPGEF6X2043</lei>
        <title>Johnson &amp; Johnson </title>
        <cusip>478160104</cusip>
        <identifiers>
          <isin value="US4781601046"/>
        </identifiers>
        <balance>280.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>63630.00000000</valUSD>
        <pctVal>1.681986733864</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zevra Therapeutics Inc</name>
        <lei>254900CU6T74V18Y1W18</lei>
        <title>Zevra Therapeutics, Inc. </title>
        <cusip>488445206</cusip>
        <identifiers>
          <isin value="US4884452065"/>
        </identifiers>
        <balance>3932.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>35388.00000000</valUSD>
        <pctVal>0.935441561181</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lenz Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>LENZ Therapeutics, Inc. </title>
        <cusip>52635N103</cusip>
        <identifiers>
          <isin value="US52635N1037"/>
        </identifiers>
        <balance>1869.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>29567.58000000</valUSD>
        <pctVal>0.781585373447</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ligand Pharmaceuticals Incorporated</name>
        <lei>5493008K7TB0IKP37H79</lei>
        <title>Ligand Pharmaceuticals, Inc. </title>
        <cusip>53220K504</cusip>
        <identifiers>
          <isin value="US53220K5048"/>
        </identifiers>
        <balance>314.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>60319.40000000</valUSD>
        <pctVal>1.594474785394</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eli Lilly &amp; Co.</name>
        <lei>FRDRIPF3EKNDJ2CQJL29</lei>
        <title>Eli Lilly &amp; Company </title>
        <cusip>532457108</cusip>
        <identifiers>
          <isin value="US5324571083"/>
        </identifiers>
        <balance>58.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>60154.70000000</valUSD>
        <pctVal>1.590121128077</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Liquidia Corporation</name>
        <lei>549300O826O5VQJTG707</lei>
        <title>Liquidia Corporation </title>
        <cusip>53635D202</cusip>
        <identifiers>
          <isin value="US53635D2027"/>
        </identifiers>
        <balance>1767.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>74903.13000000</valUSD>
        <pctVal>1.979979113388</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MBX Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>MBX Biosciences, Inc. </title>
        <cusip>55287L101</cusip>
        <identifiers>
          <isin value="US55287L1017"/>
        </identifiers>
        <balance>2003.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>73810.55000000</valUSD>
        <pctVal>1.951098002816</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Maze Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Maze Therapeutics, Inc. </title>
        <cusip>578784100</cusip>
        <identifiers>
          <isin value="US5787841007"/>
        </identifiers>
        <balance>1295.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>56436.10000000</valUSD>
        <pctVal>1.491824163304</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Merck &amp; Co., Inc</name>
        <lei>4YV9Y5M8S0BRK1RP0397</lei>
        <title>Merck &amp; Company, Inc. </title>
        <cusip>58933Y105</cusip>
        <identifiers>
          <isin value="US58933Y1055"/>
        </identifiers>
        <balance>591.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>65169.57000000</valUSD>
        <pctVal>1.722683517077</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nektar Therapeutics</name>
        <lei>5299005I24806IOIYE03</lei>
        <title>Nektar Therapeutics </title>
        <cusip>640268306</cusip>
        <identifiers>
          <isin value="US6402683063"/>
        </identifiers>
        <balance>1000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>37330.00000000</valUSD>
        <pctVal>0.986776124079</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nuvation Bio Inc</name>
        <lei>N/A</lei>
        <title>Nuvation Bio, Inc. </title>
        <cusip>67080N101</cusip>
        <identifiers>
          <isin value="US67080N1019"/>
        </identifiers>
        <balance>7365.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>38592.60000000</valUSD>
        <pctVal>1.020151520121</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ocular Therapeutix Inc</name>
        <lei>529900ABAWFXOHSIHG03</lei>
        <title>Ocular Therapeutix, Inc. </title>
        <cusip>67576A100</cusip>
        <identifiers>
          <isin value="US67576A1007"/>
        </identifiers>
        <balance>3750.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34275.00000000</valUSD>
        <pctVal>0.906020671117</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omeros Corp</name>
        <lei>549300CJWLXX2MXVVV71</lei>
        <title>Omeros Corporation </title>
        <cusip>682143102</cusip>
        <identifiers>
          <isin value="US6821431029"/>
        </identifiers>
        <balance>3019.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>35292.11000000</valUSD>
        <pctVal>0.932906818011</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Organon &amp; Co</name>
        <lei>549300AMCKY57OK2CO56</lei>
        <title>Organon &amp; Company </title>
        <cusip>68622V106</cusip>
        <identifiers>
          <isin value="US68622V1061"/>
        </identifiers>
        <balance>8042.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>68678.68000000</valUSD>
        <pctVal>1.815442851788</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pacira Biosciences Inc</name>
        <lei>549300P56LERYBDHCF69</lei>
        <title>Pacira BioSciences, Inc. </title>
        <cusip>695127100</cusip>
        <identifiers>
          <isin value="US6951271005"/>
        </identifiers>
        <balance>2293.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>47098.22000000</valUSD>
        <pctVal>1.244987918098</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pfizer Inc.</name>
        <lei>765LHXWGK1KXCLTFYQ30</lei>
        <title>Pfizer, Inc. </title>
        <cusip>717081103</cusip>
        <identifiers>
          <isin value="US7170811035"/>
        </identifiers>
        <balance>2240.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>59225.60000000</valUSD>
        <pctVal>1.565561425509</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Phathom Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Phathom Pharmaceuticals, Inc. </title>
        <cusip>71722W107</cusip>
        <identifiers>
          <isin value="US71722W1071"/>
        </identifiers>
        <balance>3421.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>46765.07000000</valUSD>
        <pctVal>1.236181476477</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Phibro Animal Health Corporation</name>
        <lei>549300U24SP4AF2JUX52</lei>
        <title>Phibro Animal Health Corporation </title>
        <cusip>71742Q106</cusip>
        <identifiers>
          <isin value="US71742Q1067"/>
        </identifiers>
        <balance>1343.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>53921.45000000</valUSD>
        <pctVal>1.425352248479</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Prestige Consumer Healthcare Inc</name>
        <lei>N/A</lei>
        <title>Prestige Consumer Healthcare, Inc. </title>
        <cusip>74112D101</cusip>
        <identifiers>
          <isin value="US74112D1019"/>
        </identifiers>
        <balance>941.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>60666.27000000</valUSD>
        <pctVal>1.603643899623</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rapport Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Rapport Therapeutics, Inc. </title>
        <cusip>75383L102</cusip>
        <identifiers>
          <isin value="US75383L1026"/>
        </identifiers>
        <balance>1926.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>51250.86000000</valUSD>
        <pctVal>1.354758236981</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Septerna Inc.</name>
        <lei>N/A</lei>
        <title>Septerna, Inc. </title>
        <cusip>81734D104</cusip>
        <identifiers>
          <isin value="US81734D1046"/>
        </identifiers>
        <balance>1042.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>24320.28000000</valUSD>
        <pctVal>0.642878961556</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Supernus Pharmaceuticals, Inc</name>
        <lei>549300GRM36VBKISYJ58</lei>
        <title>Supernus Pharmaceuticals, Inc. </title>
        <cusip>868459108</cusip>
        <identifiers>
          <isin value="US8684591089"/>
        </identifiers>
        <balance>1251.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>60248.16000000</valUSD>
        <pctVal>1.592591636959</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tarsus Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Tarsus Pharmaceuticals, Inc. </title>
        <cusip>87650L103</cusip>
        <identifiers>
          <isin value="US87650L1035"/>
        </identifiers>
        <balance>710.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>45823.40000000</valUSD>
        <pctVal>1.211289500244</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Terns Pharmaceuticals Inc.</name>
        <lei>254900S1ZDQMF4MYP709</lei>
        <title>Terns Pharmaceuticals, Inc. </title>
        <cusip>880881107</cusip>
        <identifiers>
          <isin value="US8808811074"/>
        </identifiers>
        <balance>1294.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>44772.40000000</valUSD>
        <pctVal>1.183507509716</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Trevi Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Trevi Therapeutics, Inc. </title>
        <cusip>89532M101</cusip>
        <identifiers>
          <isin value="US89532M1018"/>
        </identifiers>
        <balance>4075.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>42665.25000000</valUSD>
        <pctVal>1.127807394263</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ventyx Biosciences Inc.</name>
        <lei>N/A</lei>
        <title>Ventyx Biosciences Inc </title>
        <cusip>92332V107</cusip>
        <identifiers>
          <isin value="US92332V1070"/>
        </identifiers>
        <balance>3368.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>46983.60000000</valUSD>
        <pctVal>1.241958068665</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Viatris Inc</name>
        <lei>254900ZZTSW7NL773X71</lei>
        <title>Viatris, Inc. </title>
        <cusip>92556V106</cusip>
        <identifiers>
          <isin value="US92556V1061"/>
        </identifiers>
        <balance>4977.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>65148.93000000</valUSD>
        <pctVal>1.722137922135</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xeris Biopharma Holdings Inc</name>
        <lei>N/A</lei>
        <title>Xeris Biopharma Holdings, Inc. </title>
        <cusip>98422E103</cusip>
        <identifiers>
          <isin value="US98422E1038"/>
        </identifiers>
        <balance>8320.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>61235.20000000</valUSD>
        <pctVal>1.618682917578</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zoetis Inc.</name>
        <lei>549300HD9Q1LOC9KLJ48</lei>
        <title>Zoetis, Inc. </title>
        <cusip>98978V103</cusip>
        <identifiers>
          <isin value="US98978V1035"/>
        </identifiers>
        <balance>489.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>61036.98000000</valUSD>
        <pctVal>1.613443197157</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AGPXX</name>
        <lei>N/A</lei>
        <title>Invesco Government &amp; Agency Portfolio</title>
        <cusip>825252885</cusip>
        <identifiers>
          <isin value="US8252528851"/>
        </identifiers>
        <balance>34369.50000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34369.50000000</valUSD>
        <pctVal>0.908518671217</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="34369.50000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avadel Pharmaceuticals PLC</name>
        <lei>549300E27PTSG2RHC762</lei>
        <title>Avadel Pharmaceuticals plc </title>
        <cusip>G29687103</cusip>
        <identifiers>
          <isin value="IE00BDGMC594"/>
        </identifiers>
        <balance>2688.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57926.40000000</valUSD>
        <pctVal>1.531218550063</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Jazz Pharmaceuticals PLC</name>
        <lei>635400GAUMJCLEZRRV50</lei>
        <title>Jazz Pharmaceuticals plc </title>
        <cusip>G50871105</cusip>
        <identifiers>
          <isin value="IE00B4Q5ZN47"/>
        </identifiers>
        <balance>350.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57571.50000000</valUSD>
        <pctVal>1.521837171910</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Royalty Pharma PLC</name>
        <lei>549300FGFN7VOK8BZR03</lei>
        <title>Royalty Pharma plc </title>
        <cusip>G7709Q104</cusip>
        <identifiers>
          <isin value="GB00BMVP7Y09"/>
        </identifiers>
        <balance>1509.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>62895.12000000</valUSD>
        <pctVal>1.662561016262</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Theravance Biopharma Inc</name>
        <lei>5493007VTSXP4Z6MIW52</lei>
        <title>Theravance Biopharma, Inc. </title>
        <cusip>G8807B106</cusip>
        <identifiers>
          <isin value="KYG8807B1068"/>
        </identifiers>
        <balance>1409.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26686.46000000</valUSD>
        <pctVal>0.705426240669</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Perrigo Company PLC</name>
        <lei>549300IFOQS6R1QLY196</lei>
        <title>Perrigo Company plc </title>
        <cusip>G97822103</cusip>
        <identifiers>
          <isin value="IE00BGH1M568"/>
        </identifiers>
        <balance>4271.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>60690.91000000</valUSD>
        <pctVal>1.604295230019</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>HSBC SECURITIES (USA), INC.  3.55 , 2/02/2026</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="HSB26202"/>
        </identifiers>
        <balance>170000.00000000</balance>
        <units>PA</units>
        <curCd>USD</curCd>
        <valUSD>170000.00000000</valUSD>
        <pctVal>4.493756793288</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>RA</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <repurchaseAgrmt>
          <transCat>Repurchase</transCat>
          <notClearedCentCparty isCleared="N">
            <counterpartyInfos>
              <counterpartyInfo lei="CYYGQCGNHMHPSMRL3R97" name="HSBC SECURITIES (USA), INC."/>
            </counterpartyInfos>
          </notClearedCentCparty>
          <isTriParty>Y</isTriParty>
          <repurchaseRt>3.55000000</repurchaseRt>
          <maturityDt>2026-02-02</maturityDt>
          <repurchaseCollaterals>
            <repurchaseCollateral>
              <principalAmt>196100.00000000</principalAmt>
              <principalCd>USD</principalCd>
              <collateralVal>173591.14000000</collateralVal>
              <collateralCd>USD</collateralCd>
              <invstCat>UST</invstCat>
            </repurchaseCollateral>
          </repurchaseCollaterals>
        </repurchaseAgrmt>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>NATWEST MARKETS PLC  3.53 , 2/02/2026</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="NTM26202"/>
        </identifiers>
        <balance>177000.00000000</balance>
        <units>PA</units>
        <curCd>USD</curCd>
        <valUSD>177000.00000000</valUSD>
        <pctVal>4.678793837717</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>RA</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <repurchaseAgrmt>
          <transCat>Repurchase</transCat>
          <notClearedCentCparty isCleared="N">
            <counterpartyInfos>
              <counterpartyInfo lei="RR3QWICWWIPCS8A4S074" name="NATWEST MARKETS PLC"/>
            </counterpartyInfos>
          </notClearedCentCparty>
          <isTriParty>Y</isTriParty>
          <repurchaseRt>3.53000000</repurchaseRt>
          <maturityDt>2026-02-02</maturityDt>
          <repurchaseCollaterals>
            <repurchaseCollateral>
              <principalAmt>175800.00000000</principalAmt>
              <principalCd>USD</principalCd>
              <collateralVal>180698.85000000</collateralVal>
              <collateralCd>USD</collateralCd>
              <invstCat>UST</invstCat>
            </repurchaseCollateral>
          </repurchaseCollaterals>
        </repurchaseAgrmt>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>ROYAL BANK OF CANADA  3.45 , 2/02/2026</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="RBC26202"/>
        </identifiers>
        <balance>94000.00000000</balance>
        <units>PA</units>
        <curCd>USD</curCd>
        <valUSD>94000.00000000</valUSD>
        <pctVal>2.484783168053</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>RA</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <repurchaseAgrmt>
          <transCat>Repurchase</transCat>
          <notClearedCentCparty isCleared="N">
            <counterpartyInfos>
              <counterpartyInfo lei="ES7IP3U3RHIGC71XBU11" name="ROYAL BANK OF CANADA"/>
            </counterpartyInfos>
          </notClearedCentCparty>
          <isTriParty>Y</isTriParty>
          <repurchaseRt>3.45000000</repurchaseRt>
          <maturityDt>2026-02-02</maturityDt>
          <repurchaseCollaterals>
            <repurchaseCollateral>
              <principalAmt>95000.00000000</principalAmt>
              <principalCd>USD</principalCd>
              <collateralVal>96033.97000000</collateralVal>
              <collateralCd>USD</collateralCd>
              <invstCat>UST</invstCat>
            </repurchaseCollateral>
          </repurchaseCollaterals>
        </repurchaseAgrmt>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>SOCIETE' GENERALE  3.55 , 2/02/2026</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="SOC26202"/>
        </identifiers>
        <balance>221000.00000000</balance>
        <units>PA</units>
        <curCd>USD</curCd>
        <valUSD>221000.00000000</valUSD>
        <pctVal>5.841883831274</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>RA</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <repurchaseAgrmt>
          <transCat>Repurchase</transCat>
          <notClearedCentCparty isCleared="N">
            <counterpartyInfos>
              <counterpartyInfo lei="5493004I6N8OONF6V179" name="SOCIETE' GENERALE"/>
            </counterpartyInfos>
          </notClearedCentCparty>
          <isTriParty>Y</isTriParty>
          <repurchaseRt>3.55000000</repurchaseRt>
          <maturityDt>2026-02-02</maturityDt>
          <repurchaseCollaterals>
            <repurchaseCollateral>
              <principalAmt>224200.00000000</principalAmt>
              <principalCd>USD</principalCd>
              <collateralVal>225552.06999999</collateralVal>
              <collateralCd>USD</collateralCd>
              <invstCat>UST</invstCat>
            </repurchaseCollateral>
          </repurchaseCollaterals>
        </repurchaseAgrmt>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>UMB FINANCIAL CORP. B 3.4 , 2/02/2026</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Dummy ID" value="UMB26202"/>
        </identifiers>
        <balance>101000.00000000</balance>
        <units>PA</units>
        <curCd>USD</curCd>
        <valUSD>101000.00000000</valUSD>
        <pctVal>2.669820212482</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>RA</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <repurchaseAgrmt>
          <transCat>Repurchase</transCat>
          <notClearedCentCparty isCleared="N">
            <counterpartyInfos>
              <counterpartyInfo lei="549300MGEH3N3CUCV828" name="UMB FINANCIAL CORP."/>
            </counterpartyInfos>
          </notClearedCentCparty>
          <isTriParty>Y</isTriParty>
          <repurchaseRt>3.40000000</repurchaseRt>
          <maturityDt>2026-02-02</maturityDt>
          <repurchaseCollaterals>
            <repurchaseCollateral>
              <principalAmt>100700.00000000</principalAmt>
              <principalCd>USD</principalCd>
              <collateralVal>103118.23999999</collateralVal>
              <collateralCd>USD</collateralCd>
              <invstCat>UST</invstCat>
            </repurchaseCollateral>
          </repurchaseCollaterals>
        </repurchaseAgrmt>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Wave Life Sciences Ltd.</name>
        <lei>54930070006GPKFYZ813</lei>
        <title>WaVe Life Sciences Ltd. </title>
        <cusip>Y95308105</cusip>
        <identifiers>
          <isin value="SG9999014716"/>
        </identifiers>
        <balance>2854.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>36930.76000000</valUSD>
        <pctVal>0.976222668419</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <signature>
      <ncom:dateSigned>2026-01-31</ncom:dateSigned>
      <ncom:nameOfApplicant>Pharmaceuticals UltraSector ProFund</ncom:nameOfApplicant>
      <ncom:signature>Rebecca Colvin </ncom:signature>
      <ncom:signerName>Rebecca Colvin </ncom:signerName>
      <ncom:title>Treasurer and Principal Financial Officer </ncom:title>
    </signature>
  </formData>
</edgarSubmission>
